Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-08-29FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for a generic pramipexole dihydrochloride product from Torrent Pharmaceuticals Limited, for the trea…
-
CLINICAL_TRIALS trial_result · 2011-08-26Clinical Trial Update: A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy to L-dopa in the Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations and Dyskinesia. [Phase 2]
A Phase 2 pilot study evaluating Pardoprunox as an add-on to L-dopa in advanced Parkinson's disease with motor fluctuations and dyskinesia w…
-
CLINICAL_TRIALS trial_result · 2011-08-25Clinical Trial Update: Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD). [Phase 3]
The document presents long-term safety findings from an open-label study of pramipexole extended-release in patients with early Parkinson di…
-
FDA approval · 2011-08-22FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved a supplemental application for pramipexole dihydrochloride submitted by Torrent Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2011-08-18Clinical Trial Update: Telephone Call From Acute Care Physicians to Long Term Care Physicians: Impact on Transitional Care of Elderly Patients [Phase 1]
Phase 1 clinical trial update examining whether structured telephone communication between acute care and long-term care physicians improves…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-08-16Clinical Trial Update: Efficacy and Safety of Green Tea Polyphenol in De Novo Parkinson's Disease Patients [Phase 2]
A Phase 2 trial evaluated the efficacy and safety of a green tea polyphenol in de novo Parkinson's disease patients. The study sponsored by …
-
CLINICAL_TRIALS trial_result · 2011-08-16Clinical Trial Update: Efficacy and Safety of Lingzhi in Patients With Early Parkinson's Disease [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of Lingzhi in patients with early Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2011-08-15Clinical Trial Update: Cholinergic Augmentation in Frequently Falling Subjects With Parkinson's Disease [NA]
A completed clinical trial evaluated cholinergic augmentation to reduce falls in people with Parkinson's disease; results were posted in Aug…
-
CLINICAL_TRIALS research · 2011-08-15Clinical Trial Update: Treatment of Depression in Parkinson's Disease [Phase 2]
A Phase 2 clinical trial is evaluating treatment for depression in Parkinson's disease. The current status is unknown.
-
FDA approval · 2011-08-11FDA Approved: CABERGOLINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for cabergoline from Mylan Pharmaceuticals Inc., updating the product's labeling.
-
FDA approval · 2011-08-01FDA Approved: AMANTADINE HCL — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for amantadine hydrochloride (amantadine HCl) submitted by Bionpharma Inc.
-
CLINICAL_TRIALS trial_result · 2011-07-27Clinical Trial Update: Balance Training in Parkinson's Disease Using the Wii Balance Board [NA]
A completed clinical trial evaluated balance training for Parkinson's disease using the Nintendo Wii Balance Board.
-
CLINICAL_TRIALS trial_result · 2011-07-26Clinical Trial Update: Perioperative Treatment of Parkinsonian Patients With Parenteral Amantadine [Phase 2]
A Phase 2 trial evaluating parenteral amantadine for perioperative care in Parkinson disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-07-25Clinical Trial Update: PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets [Phase 1, Phase 2]
Early-phase trial comparing multiple-dose PK/PD and safety of V1512 tablets against standard Levodopa/Carbidopa in Parkinson's disease patie…
-
CLINICAL_TRIALS trial_result · 2011-07-19Clinical Trial Update: Survey on PD Patients With Depressive Symptoms
This entry reports a completed clinical trial survey on depressive symptoms in Parkinson disease. Results were posted on 2011-07-19.
-
FDA approval · 2011-07-18FDA Approved: CABERGOLINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for cabergoline filed by Mylan Pharmaceuticals Inc., resulting in a revised label and potential expa…
-
CLINICAL_TRIALS trial_result · 2011-07-14Clinical Trial Update: Long-term Safety Study of Open-label Pramipexole ER in Patients With Advanced PD [Phase 3]
A Phase 3 long-term open-label safety study of pramipexole extended-release in patients with advanced Parkinson disease was conducted; resul…
-
CLINICAL_TRIALS trial_result · 2011-07-12Clinical Trial Update: The Effect of High-Volume Walking With Visual Cues (VC) in Parkinson´s Disease (PD) [Phase 3]
Phase 3 trial evaluating high-volume walking with visual cues for Parkinson's disease has completed. The update may inform future developmen…
-
CLINICAL_TRIALS trial_result · 2011-07-08Clinical Trial Update: Study of Magnetic Fields for Treatment of Parkinson's Disease [Phase 2]
Phase 2 clinical trial evaluating Pico-Tesla Magnetic Field Therapy for Parkinson's disease has completed and results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-07-08Clinical Trial Update: Evaluation of Long-term Effect of Resonator Therapy on Parkinson's Disease (PD)
A completed study evaluated the long-term effects of Resonator Therapy on Parkinson's disease. Results were posted on 2011-07-08.
-
FDA approval · 2011-07-05FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved a supplemental application for Carbidopa and Levodopa submitted by Dr. Reddy's Laboratories Inc.
-
FDA approval · 2011-07-05FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Dr. Reddy's Laboratories Inc)
The FDA approved a supplemental application for a generic carbidopa-levodopa product from Dr. Reddy's Laboratories Inc. This action expands …
-
FDA approval · 2011-07-05FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved a supplemental application for Dr. Reddy's Laboratories' generic carbidopa and levodopa.
-
CLINICAL_TRIALS trial_result · 2011-07-01Clinical Trial Update: Parkinson's Disease Isradipine Safety Study [Phase 2]
Phase 2 safety study update for isradipine in Parkinson's disease completed with results posted in 2011.
-
FDA approval · 2011-06-30FDA Approved: TRIHEXYPHENIDYL HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
The FDA approved a supplemental ANDA for Trihexyphenidyl hydrochloride (generic) filed by PAI Holdings, LLC dba PAI Pharma. The approval all…